Therefore, biomarkers specific to the prostate gland (eg, prostate specific antigen (PSA), which reflects both normal and prostate cancer epithelium) should become undetectable after surgery, but this is not the case when RT is used, as residual prostate cells may still be metabolically active and produce markers. This evidence concerns the gene KLK3 and prostate carcinoma.